Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Debt to Equity (2021 - 2023)

Historic Debt to Equity for Pulse Biosciences (PLSE) over the last 3 years, with Q1 2023 value amounting to -$6.09.

  • Pulse Biosciences' Debt to Equity changed N/A to -$6.09 in Q1 2023 from the same period last year, while for Mar 2023 it was -$6.09, marking a year-over-year change of. This contributed to the annual value of -$28.91 for FY2022, which is N/A changed from last year.
  • As of Q1 2023, Pulse Biosciences' Debt to Equity stood at -$6.09.
  • Pulse Biosciences' Debt to Equity's 5-year high stood at $10.5 during Q3 2022, with a 5-year trough of -$28.91 in Q4 2022.
  • For the 3-year period, Pulse Biosciences' Debt to Equity averaged around -$5.62, with its median value being -$2.04 (2021).